Search Tag: multiparametric MRI
2025 13 Aug
Prostate cancer remains one of the most prevalent malignancies among men, with early and accurate detection being essential to improve treatment outcomes. Advances in deep learning have led to the development of diagnostic models capable of matching or even surpassing radiologists in certain tasks. These systems typically require large, diverse...Read more
2025 13 Aug
Prostate cancer remains one of the most prevalent malignancies among men, with early and accurate detection being essential to improve treatment outcomes. Advances in deep learning have led to the development of diagnostic models capable of matching or even surpassing radiologists in certain tasks. These systems typically require large, diverse...Read more
2025 13 Aug
Prostate cancer remains one of the most prevalent malignancies among men, with early and accurate detection being essential to improve treatment outcomes. Advances in deep learning have led to the development of diagnostic models capable of matching or even surpassing radiologists in certain tasks. These systems typically require large, diverse...Read more
2025 17 May
Locally advanced rectal cancer (LARC) presents a formidable clinical challenge, with early recurrence (ER) often signalling a more aggressive tumour phenotype and poor prognosis. Traditional methods for risk assessment, based largely on clinical markers such as carcinoembryonic antigen (CEA) and MRI-assessed features, offer limited accuracy due to...Read more
2025 17 May
Locally advanced rectal cancer (LARC) presents a formidable clinical challenge, with early recurrence (ER) often signalling a more aggressive tumour phenotype and poor prognosis. Traditional methods for risk assessment, based largely on clinical markers such as carcinoembryonic antigen (CEA) and MRI-assessed features, offer limited accuracy due to...Read more
2025 17 Apr
The clinical deployment of artificial intelligence (AI) in prostate cancer detection is advancing rapidly, particularly in the use of multiparametric MRI for diagnosing clinically significant prostate cancer (csPCa) in biopsy-naive men. These patients typically present with elevated prostate-specific antigen (PSA) levels or abnormal digital rectal...Read more
2025 17 Apr
The clinical deployment of artificial intelligence (AI) in prostate cancer detection is advancing rapidly, particularly in the use of multiparametric MRI for diagnosing clinically significant prostate cancer (csPCa) in biopsy-naive men. These patients typically present with elevated prostate-specific antigen (PSA) levels or abnormal digital rectal...Read more
2025 25 Mar
The role of magnetic resonance imaging (MRI) in prostate cancer diagnosis has become increasingly significant, particularly through multiparametric MRI (mpMRI). This approach incorporates T2-weighted imaging, diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) imaging, often using gadolinium-based contrast agents. However, the...Read more
2025 17 Mar
Focal therapy has emerged as a promising alternative to whole-gland treatments for prostate cancer, aiming to balance oncologic control with reduced adverse effects. Traditional methods, like radical prostatectomy and radiation therapy, provide well-documented long-term outcomes but often lead to significant morbidities such as urinary incontinence...Read more
2024 02 May
Active surveillance (AS) is endorsed by the European Association of Urology (EAU) for low to favourable intermediate-risk prostate cancer (PCa) patients. It aims to delay or avoid radical treatments while maintaining oncological outcomes. AS's safety is supported by trials like ProtecT and PIVOT, despite potential understaging and undergrading....Read more